MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
29.52 CAD
+0.6 (+2.07%)
Taking everything into account, MDA scores 6 out of 10 in our fundamental rating. MDA was compared to 13 industry peers in the Aerospace & Defense industry. MDA has only an average score on both its financial health and profitability. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
MDA's Return On Assets of 3.15% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
MDA has a Return On Equity of 8.24%. This is in the better half of the industry: MDA outperforms 76.92% of its industry peers.
MDA's Return On Invested Capital of 5.12% is on the low side compared to the rest of the industry. MDA is outperformed by 61.54% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.00%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA has a Profit Margin of 7.40%. This is in the better half of the industry: MDA outperforms 76.92% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA has a worse Operating Margin (9.86%) than 61.54% of its industry peers.
MDA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.62%, MDA is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
The number of shares outstanding for MDA has been increased compared to 1 year ago.
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.47, we must say that MDA is in the distress zone and has some risk of bankruptcy.
MDA has a Altman-Z score of 1.47. This is in the better half of the industry: MDA outperforms 76.92% of its industry peers.
The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
MDA's Debt to FCF ratio of 0.92 is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.47 |
ROIC/WACC0.6
WACC8.54%
2.3 Liquidity
MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a Current ratio of 0.55. This is amonst the worse of the industry: MDA underperforms 84.62% of its industry peers.
MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a Quick ratio (0.54) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.77%.
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.78% on average per year.
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.84% on average per year.
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated quite expensively with a Price/Earnings ratio of 26.12.
MDA's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of MDA to the average of the S&P500 Index (27.25), we can say MDA is valued inline with the index average.
MDA is valuated rather expensively with a Price/Forward Earnings ratio of 18.98.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MDA to the average of the S&P500 Index (23.98), we can say MDA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.12 | ||
| Fwd PE | 18.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8 | ||
| EV/EBITDA | 14.98 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.78% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y49.06%
EPS Next 3Y35.78%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (1/9/2026, 7:00:00 PM)
29.52
+0.6 (+2.07%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap3.73B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.46
Price Target40.74 (38.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)3.25%
PT rev (3m)-6.95%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.12 | ||
| Fwd PE | 18.98 | ||
| P/S | 2.52 | ||
| P/FCF | 8 | ||
| P/OCF | 5.07 | ||
| P/B | 2.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.98 |
EPS(TTM)1.13
EY3.83%
EPS(NY)1.56
Fwd EY5.27%
FCF(TTM)3.69
FCFY12.51%
OCF(TTM)5.82
OCFY19.73%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.25
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.47 |
F-Score6
WACC8.54%
ROIC/WACC0.6
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
Can you provide the valuation status for MDA SPACE LTD?
ChartMill assigns a valuation rating of 5 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the financial health of MDA SPACE LTD (MDA.CA) stock?
The financial health rating of MDA SPACE LTD (MDA.CA) is 4 / 10.
What is the earnings growth outlook for MDA SPACE LTD?
The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.